On September 5, 2024, the FDA warned consumers not to purchase or use Umary Hyaluronic Acid or Amazy Hyaluronic Acid supplements because testing by the agency found them to contain diclofenac and omeprazole. These drugs are not permitted to be sold as ingredients in dietary supplements and are not listed on the product labels.

See ConsumerLab’s Review of Joint Health Supplements for more information about hyaluronic acid and tests of related supplements.

Diclofenac is a prescription non-steroidal anti-inflammatory drug (NSAID) that can cause serious cardiovascular events such as heart attack or stroke, as well as bleeding, ulceration, and fatal tears of the stomach and intestines. When interacting with other medications, diclofenac can significantly increase the risk for adverse events. Taking multiple products containing NSAIDS increases these risks.

Omeprazole is a proton pump inhibitor (also known as PPI) and is used for stomach acid disorders. PPI medications may cause skin reactions, abdominal pain, diarrhea, nausea, and headache. Omeprazole should not be taken with certain medications as it may hide potential stomach issues including erosions, ulcers, or stomach cancer.

Umary and Amazy hyaluronic acid supplements are promoted to treat pain and other conditions, and are sold on various websites, including Amazon, SoloVital, Main Products, and in some retail stores.

The presence of diclofenac in Umary supplements was first reported in Canada in April 2024. In July 2024, Umary Hyaluronic Acid capsules were recalled by U.S. retailer SoloVital.com after FDA testing found them to contain unlisted diclofenac and omeprazole. The FDA noted it has seen an increase in fraudulent supplements promoted to treat pain that contain hidden ingredients and advised consumers to use caution when considering purchasing these types of products.

Consumers should contact their healthcare provider if they have experienced any problems related to taking these drug products. Consumers and or healthcare providers are advised to report any adverse reactions to the FDA’s MedWatch Voluntary Reporting Program by fax, mail, or online.

For more information, use the link below.

FDA warns consumers not to purchase or use Umary and Amazy products as they may be harmful to your health

See related recalls and warnings

Umary Hyaluronic Acid Supplement Recalled

Drug Found in Umary Supplement

Pain Relief Tea Recalled, Found to Contain Prescription Drugs

Joint Pain Supplements Recalled Due to Undeclared Drug Ingredients

FDA Warns Consumers Not to Use Tapee Tea